Sugar Derivatives TRIZ Cases

Segmenting the probe into a stabilizing mask and specific detection region resolves binding stability versus SNV discrimination trade-offs.

Integration defective lentiviral vectors with miRNA regulation achieve transient gene expression, avoiding insertional mutagenesis risks.

A two-step process uses E. coli fermentation to generate O-acetylhomserine, followed by enzymatic conversion to L-methionine.

A TMV-inducible pepper promoter uses Dof1 binding to regulate target protein expression.

Conjugating terpyridine to LNA oligonucleotides improves cellular distribution and therapeutic efficacy for hard-to-transfect cells.

Antisense oligomers target conserved genomic regions to treat SARS-CoV-2, addressing the lack of established therapies.

Barcoded PCR amplification maps insertion sites at 8 bp resolution, bypassing labor-intensive individual clone processing.

Segmented protecting groups prevent side reactions in bis-protected guanine monomers, reducing by-products and boosting yields.

Computational platform maps codon sequence space to optimize polynucleotide design parameters.

Bis-boron fused heterocyclic dyes maintain strong fluorescence in aqueous buffers, resolving the contradiction between intensity and stability.

Quaternary stereogenic nucleoside analogues with lipoate derivatives extend half-life time to overcome Gemcitabine resistance.

T4 DNA ligase joins phosphorylated oligonucleotides into multimers that stimulate immune cells.

A tricyclic cytosine analogue incorporates directly into RNA to enable live cell imaging without bulky external labels.

Conjugating oligocation moieties to primer 5' ends reduces electrostatic repulsion, improving sensitivity and sequence coverage for trace DNA amounts.

Segmented amplicons assemble into full-length polynucleotide variants, reducing oligonucleotide synthesis costs and increasing correct sequence yield.

Beta zeolite catalysts with tin or titanium centers convert glucose to fructose, maintaining activity across multiple cycles without enzyme replacement.

Clay minerals protect nucleic acids during alkaline lysis, eliminating nuclease degradation and hazardous chemical steps in blood diagnostics.

Multi-SNP genotyping improves measurement precision for early coronary heart disease risk assessment.

Engineered rodents expressing humanized MHC class II proteins enable accurate identification of peptides that activate human T cells for vaccine development.

Selective bond cleavage in a carrier group enables real-time photon signaling to verify nucleotide attachment accuracy during DNA synthesis.

Assigning unique signal ratios to nucleotide bases reduces optical system complexity and cost while maintaining high-throughput sequencing accuracy.

Segmented riboregulators overcome sequence constraints by using a linear toehold domain to activate translation, enabling real-time RNA sensing.

Engineered Sox7 and Sox17 proteins acquire high affinity for Oct4 through targeted amino acid mutations.

Shared electrode leads combined with fixed potentials on inactive channels minimize electrical cross-talk in compact biosensor arrays.

Nested PCR using chimeric primers resolves the contradiction between amplification efficiency and nucleotide stability for non-standard bases.

Segmented filtration membranes remove inhibitory agents from blood to improve PCR sensitivity and specificity for microbial identification.

A thermolabile uracil-DNA glycosylase inactivates via heating to prevent non-specific degradation during enzymatic reactions.

Targeting SIRT6 via microRNAs resolves the trade-off between disease regulation and limited lifespan extension found with other sirtuins.

Engineered ZmCAS1 promoter resolves the trade-off between high RNA synthesis rates and external regulation by introducing heat-responsive mutations.

Orthogonal protecting groups enable stereoselective glycosidic bond formation, resolving low yields in glucuronic acid reactions.

An excisable nucleic acid construct uses homing endonucleases to cleave target sequences from the host genome.

A polymerase enzyme substrate uses a protein shield to separate fluorescent dyes from the enzyme active site, preventing photodamage during sequencing.

A solvent-mediated glycosylation method produces trifluridine intermediates with controlled configuration ratios using specific acid catalysts.

Cyclic-di-AMP sodium salt crystals resist degradation at 105°C, solving the instability of free acid forms during large-scale production.

Aptamer-based functional ligands target LL37 to inhibit autoimmune responses in psoriasis and rosacea without suppressing the entire immune system.

Recombinant host cells expressing pyruvate carboxylase produce C4 dicarboxylic acids via fermentation, eliminating harmful chemical synthesis by-products.

Non-enzymatic hybridization chain reaction replaces QPCR enzymes, resolving sensitivity and consistency trade-offs in complex samples.

Chromatography with macroporous neutral resin separates rebaudioside B and D to reduce bitterness and improve sweetness profiles.

Synthetic glycopolymers inhibit RANTES binding to treat inflammation without heparin-induced thrombocytopenia.

A polyvalent polymer hub enables liquid phase oligonucleotide synthesis with improved yield and efficiency.

Segmented enzymatic saccharification followed by molecular sieving reduces glucose and oligosaccharide impurities in maltitol production.

Replacing hazardous azide intermediates with oxime pathways eliminates safety risks while improving yield and purity in commercial-scale nucleoside production.

Cyclobutene monomers replace norbornene derivatives to resolve stereochemical unpredictability in ring opening metathesis polymerization.

Modified phosphate linkages in cap analogs resist enzymatic degradation while preserving eIF4E binding for stable protein production.

Segmented synthesis using chiral oxathiaphospholane sulfides establishes stereochemical configuration early, resolving yield loss in longer oligonucleotides.

Modular integration of heterologous genes into yeast genomes overcomes low yield bottlenecks to achieve 1.5 g/L cytokinin concentrations.